Michele M. Hickey - Concepedia

Author

Michele M. Hickey

Also Known As

M M Hickey, Michele Hickey, Michele M Hickey, Michele M. Hickey, Michele M. Hickey, Rathmell, W. Kimryn, Richmond, Terri D

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Howard Hughes Medical Institute UNC Lineberger Comprehensive Cancer Center Cancer Research Institute of the Slovak Academy of Sciences University of North Carolina at Chapel Hill

About

Michele M. Hickey is an author at University of Pennsylvania specializing in medicine, cell biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	216
2	Cell Biology	3	3	175
3	Cell Signaling	2	2	112
4	Immunology	1	1	32
5	Pathology	1	1	41

Michele M. Hickey

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation Hongxia Z. Imtiyaz, Emily Williams, Michele M. Hickey, Journal of Clinical Investigation	2010	443
The von Hippel–Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice Michele M. Hickey, Theresa Richardson, Tao Wang, Journal of Clinical Investigation	2010	138
HIF-2α deletion promotes Kras-driven lung tumor development Jolly Mazumdar, Michele M. Hickey, Dhruv K. Pant, Proceedings of the National Academy of Sciences	2010	129
von Hippel–Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2α signaling and splenic erythropoiesis Michele M. Hickey, Jennifer C. Lam, Natalie Bezman, Journal of Clinical Investigation	2007	107
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia Ryan C. Russell, Roxana I. Sufan, Bing Zhou, Nature Medicine Transcriptional RegulationSignal TransductionCell RegulationMolecular RegulationHematology	2011	80
<b> <i>In vitro</i> </b> and <b> <i>In vivo</i> </b> Models Analyzing von Hippel-Lindau Disease-Specific Mutations W. Kimryn Rathmell, Michele M. Hickey, Natalie Bezman, Cancer Research	2004	64
PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells Gilles Buchwalter, Michele M. Hickey, Anne Cromer, Cancer Cell Survival FactorBreast OncologyOncologyMedicineCancer Growth	2013	63
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo C M Lee, Michele M. Hickey, Christie A. Sanford, Oncogene Somatic VariantHif DosageGenetic DisorderGeneticsHematology	2009	41
Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression Hsin‐Ching Lin, Michele M. Hickey, Lydia Hsu, Virology Human RetrovirusImmunologyCellular Promoter ElementsCellular Immune ResponseAdult T-cell Leukemia-lymphoma	2005	32

Page 1